Departments of Pharmaceutical and Administrative Sciences, Loma Linda University Schools of Pharmacy and Medicine, Loma Linda, CA, 92350, USA.
Departments of Pharmaceutical and Administrative Sciences, Loma Linda University Schools of Pharmacy and Medicine, Loma Linda, CA, 92350, USA.
Neuropharmacology. 2018 Mar 15;131:431-439. doi: 10.1016/j.neuropharm.2018.01.015. Epub 2018 Jan 13.
Amphetamine-like psychostimulants, including methylphenidate, have been shown to produce two opposing effects on dopamine (DA) neurons: a DA receptor-mediated feedback inhibition and a non-DA receptor-mediated excitation. To test whether the latter effect is mediated through the prefrontal cortex (PFC), we made dual-site recordings from the PFC and ventral tegmental area (VTA). Consistent with previous reports, methylphenidate inhibited VTA DA neurons. The D2 receptor antagonist raclopride completely reversed the inhibition and further increased the activity, particularly bursting, to above pre-drug baseline. This increase in DA cell activity was blocked by the α1 receptor antagonist prazosin, suggesting an effect mediated through α1 receptors. Recordings in the PFC showed that methylphenidate increased PFC UP state duration and shifted the functional coupling between the PFC and DA neurons from negative to positive. The former effect was partially reversed by not only prazosin, but also raclopride, whereas the latter was reversed only by raclopride. These results suggest that methylphenidate increases PFC cell activity through both α1 and D2 receptors. Its effect on PFC-DA cell functional coupling, however, is mediated through D2 receptors. The finding that the latter effect was unaffected by prazosin further suggests that it does not play a significant role in the α1-mediated excitatory effect of methylphenidate on DA neurons. However, the shift in PFC-DA cell functional coupling from negative to positive may significantly alter the relative timing between DA and glutamate release from DA and PFC terminals and thus the synaptic plasticity that depends on DA-glutamate interaction.
苯丙胺类兴奋剂,包括哌甲酯,已被证明对多巴胺(DA)神经元产生两种相反的作用:DA 受体介导的反馈抑制和非 DA 受体介导的兴奋。为了测试后者是否通过前额叶皮层(PFC)介导,我们从前额叶皮层(PFC)和腹侧被盖区(VTA)进行了双位点记录。与之前的报告一致,哌甲酯抑制 VTA DA 神经元。D2 受体拮抗剂氯丙嗪完全逆转了抑制作用,并进一步增加了活动,特别是爆发,高于药物前基线。这种 DA 细胞活动的增加被 α1 受体拮抗剂哌唑嗪阻断,表明这是通过 α1 受体介导的作用。PFC 的记录显示,哌甲酯增加了 PFC UP 状态的持续时间,并将 PFC 和 DA 神经元之间的功能耦合从负向变为正向。氯丙嗪不仅部分逆转了前一种效应,而且部分逆转了后一种效应,而氯丙嗪仅部分逆转了后一种效应。这些结果表明,哌甲酯通过 α1 和 D2 受体增加 PFC 细胞的活动。然而,它对 PFC-DA 细胞功能耦合的影响是通过 D2 受体介导的。氯丙嗪对后者没有影响的发现进一步表明,它在 α1 介导的哌甲酯对 DA 神经元的兴奋作用中不起重要作用。然而,PFC-DA 细胞功能耦合从负向到正向的转变可能会显著改变 DA 和谷氨酸从 DA 和 PFC 末梢释放的相对时间,从而改变依赖于 DA-谷氨酸相互作用的突触可塑性。